Ignite Creation Date:
2025-12-24 @ 7:39 PM
Ignite Modification Date:
2025-12-29 @ 6:47 AM
Study NCT ID:
NCT04826003
Status:
COMPLETED
Last Update Posted:
2025-07-14
First Post:
2021-03-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study To Evaluate Safety, Pharmacokinetics, Pharmacodynamics, And Preliminary Anti-Tumor Activity Of RO7122290 In Combination With Cibisatamab With Obinutuzumab Pre-Treatment
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07-14
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-11-11
Completion Date Type:
ACTUAL
First Submit Date:
2021-03-16
First Submit QC Date:
None
Study First Post Date:
2021-04-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-09
Last Update Post Date:
2025-07-14
Last Update Post Date Type:
ACTUAL